Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-08-15

Clinical Trial Update: Evaluation of Safety of Acellular Dermal Matrix(ADM) in Breast Reconstruction

View source ↗

Summary

Clinical trial evaluating the safety of acellular dermal matrix (ADM) in breast reconstruction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Acellular Dermal Matrix

Snippet

Sponsor: DOF Inc. | Conditions: Breast Cancer Female, Breast Reconstruction | Status: RECRUITING